Skip to main content
. 2020 Feb 7;8(1):73. doi: 10.3390/vaccines8010073

Table 1.

Synthetic BclA3 peptides.

Peptide Name Sequence (R20291 BclA3) Tag/Conjugate
(BclA3 aa Sequence)
SML1 (308–319) 12 aa AGLIGPTGATGV FITC-Ahx
SML2 (391–404) 15 aa VGPTGATGATGADGV FITC-Ahx
SML3 (278–292) 15 aa TGATGLIGPTGATGA FITC-Ahx
SML4 (391–404) 15 aa VGPTGATGATGADGV KLH and BSA conjugate
SML9 (271–295) 25 aa GATGIGITGATGLIGPTGATGATGA FITC-Ahx
SML10 (278–292) 16 aa (C)TGATGLIGPTGATGA N terminal cysteine/KLH and BSA conjugate
SML11 single site DGAVGLIGPTGAGADGA FITC-Ahx
SML12 T to S, 4 sites SGASGLIGPSGAGASGA FITC-Ahx
SML13 single T site DGATGLIGPDGAGADGA FITC-Ahx
SML14 single S site DGASGLIGPDGAGADGA FITC-Ahx
SML7 (1–15) 15aa (C)MSRNKYFGPFDDNDYN N terminal cysteine/BSA conjugate
SML8 (46–60) 15aa (C)VGPTGPMGPRGRTGP N terminal cysteine/ BSA conjugate